Stay updated on LAP of Mepolizumab for MEA115921 Participants Clinical Trial
Sign up to get notified when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.

Latest updates to the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; deleted the funding-lapse notice and Revision: v3.4.1. No study content changes are present.SummaryDifference0.3%

- Check41 days agoChange DetectedNotice of government funding lapse and an updated Revision: v3.4.1 were added; no changes to core study content or data are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a glossary display, introduced a QC status field (Last Update Submitted that Met QC Criteria), and updated the page revision to v3.4.0. Removed the older No FEAR Act data label and the previous revision text (v3.3.4).SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a minor administrative revision tag update from v3.3.3 to v3.3.4 without changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations were expanded with new sites across the US, Canada, and Europe. The page revision is now v3.3.3.SummaryDifference2%

Stay in the know with updates to LAP of Mepolizumab for MEA115921 Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.